HK1045518A1 - 用作抗病毒劑的4-氧代-4,7-二氫-噻吩並[2,3-b]吡啶-5-甲酰胺類化合物 - Google Patents

用作抗病毒劑的4-氧代-4,7-二氫-噻吩並[2,3-b]吡啶-5-甲酰胺類化合物

Info

Publication number
HK1045518A1
HK1045518A1 HK02107054.6A HK02107054A HK1045518A1 HK 1045518 A1 HK1045518 A1 HK 1045518A1 HK 02107054 A HK02107054 A HK 02107054A HK 1045518 A1 HK1045518 A1 HK 1045518A1
Authority
HK
Hong Kong
Prior art keywords
carb
thieno
dihydro
oxo
pyridine
Prior art date
Application number
HK02107054.6A
Other languages
English (en)
Inventor
M‧E‧施努特
M‧M‧卡達希
A‧斯科特
Original Assignee
法瑪西雅厄普約翰美國公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 法瑪西雅厄普約翰美國公司 filed Critical 法瑪西雅厄普約翰美國公司
Publication of HK1045518A1 publication Critical patent/HK1045518A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
HK02107054.6A 1999-03-09 2002-09-26 用作抗病毒劑的4-氧代-4,7-二氫-噻吩並[2,3-b]吡啶-5-甲酰胺類化合物 HK1045518A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12366099P 1999-03-09 1999-03-09
PCT/US2000/005937 WO2000053610A2 (en) 1999-03-09 2000-03-07 4-OXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS

Publications (1)

Publication Number Publication Date
HK1045518A1 true HK1045518A1 (zh) 2002-11-29

Family

ID=22410054

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107054.6A HK1045518A1 (zh) 1999-03-09 2002-09-26 用作抗病毒劑的4-氧代-4,7-二氫-噻吩並[2,3-b]吡啶-5-甲酰胺類化合物

Country Status (25)

Country Link
US (2) US6239142B1 (zh)
EP (1) EP1159279B1 (zh)
JP (1) JP2002539130A (zh)
KR (1) KR20010102543A (zh)
CN (1) CN1347417A (zh)
AT (1) ATE226208T1 (zh)
AU (1) AU759875B2 (zh)
BR (1) BR0008804A (zh)
CA (1) CA2366609A1 (zh)
CZ (1) CZ20013028A3 (zh)
DE (1) DE60000611T2 (zh)
DK (1) DK1159279T3 (zh)
EA (1) EA003607B1 (zh)
ES (1) ES2184705T3 (zh)
HK (1) HK1045518A1 (zh)
HU (1) HUP0200324A3 (zh)
IL (1) IL145005A0 (zh)
NO (1) NO20014363L (zh)
NZ (1) NZ513758A (zh)
PL (1) PL350651A1 (zh)
PT (1) PT1159279E (zh)
SK (1) SK12582001A3 (zh)
TW (1) TWI222451B (zh)
WO (1) WO2000053610A2 (zh)
ZA (1) ZA200107255B (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US8101629B2 (en) 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
WO2003020728A1 (en) * 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
MXPA04001797A (es) 2001-08-30 2004-07-08 Pharmacia & Upjhon Company 4-tioxo-4,7-dihidro-teno[2,3-b]piridin-5-carboxamidas como agentes antivirales.
CN1620439A (zh) * 2001-12-20 2005-05-25 Osi药物公司 胰脂肪酶抑制剂化合物、其合成方法和应用
AR038118A1 (es) * 2002-01-14 2004-12-29 Upjohn Co Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
AR038294A1 (es) 2002-01-14 2005-01-12 Upjohn Co Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
AR038117A1 (es) * 2002-01-14 2004-12-29 Upjohn Co Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
AU2003222077A1 (en) * 2002-04-22 2003-11-03 Pharmacia And Upjohn Company A trifluoroacetic acid process to prepare (2,3-b)pyridine intermediates
BR0313545B1 (pt) 2002-08-09 2021-07-27 Janssen Pharmaceutica Nv processos para a preparação de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrila
WO2004019932A1 (en) * 2002-08-30 2004-03-11 Pharmacia & Upjohn Company Method of preventing or treating atherosclerosis or restenosis
WO2004019939A1 (en) * 2002-08-30 2004-03-11 Pharmacia & Upjohn Company Method of preventing or treating atherosclerosis or restenosis
WO2004019933A1 (en) * 2002-08-30 2004-03-11 Pharmacia & Upjohn Company Method of preventing or treating atherosclerosis or restenosis
WO2004019940A1 (en) * 2002-08-30 2004-03-11 Pharmacia & Upjohn Company Method of preventing or treating atherosclerosis or restenosis
AU2003265385A1 (en) * 2002-09-04 2004-03-29 Pharmacia & Upjohn Company Llc Aryl-ethanolamine derivatives as antiviral agents
AU2003304151A1 (en) * 2002-09-04 2005-01-21 Pharmacia And Upjohn Company Heteroaryl-ethanolamine derivatives as antiviral agents
AU2003269950A1 (en) * 2002-09-04 2004-03-29 Pharmacia & Upjohn Company Llc Heteroaryl-ethanolamine derivatives as antiviral agents
WO2004022566A1 (en) * 2002-09-04 2004-03-18 Pharmacia & Upjohn Company Llc 4-OXO-4,7-DIHYDROTHIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
WO2005003140A1 (en) * 2003-07-02 2005-01-13 Pharmacia & Upjohn Company Llc 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
EP1756082A1 (en) * 2004-04-13 2007-02-28 Astex Therapeutics Limited 5-morpholinylmethylthiophenyl pharmaceutial compounds as p38 map kinase modulators
SE0401578D0 (sv) 2004-06-18 2004-06-18 Active Biotech Ab Novel compounds
WO2006093518A2 (en) * 2004-06-25 2006-09-08 Apath, Llc Thienyl compounds for treating virus-related conditions
AP3069A (en) * 2009-02-27 2014-12-31 Siga Technologies Inc Thienopyridine derivatives for the treatment and prvention of dengue virus infection
JP2019504901A (ja) 2016-02-16 2019-02-21 ヴァンダービルト ユニバーシティー ムスカリン性アセチルコリン受容体m1のポジティブアロステリックモジュレーター
WO2018063552A1 (en) * 2016-09-30 2018-04-05 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor m1
CN112996789A (zh) 2018-09-12 2021-06-18 诺华股份有限公司 抗病毒吡啶并吡嗪二酮化合物
AU2020353055B2 (en) 2019-09-26 2024-03-07 Gilead Sciences, Inc. Antiviral pyrazolopyridinone compounds
CN115073489B (zh) * 2021-03-15 2023-11-28 同济大学 一种噻吩骈吡啶酮类化合物、制备方法及一种抗真菌药物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5268193A (en) 1975-11-28 1977-06-06 Sumitomo Chem Co Ltd Synthesis of novel cephalosporin derivatives
US4145418A (en) 1976-01-06 1979-03-20 Takeda Chemical Industries, Ltd. Thienopyridine substituted cephalosporins
US4568649A (en) 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4767766A (en) 1987-01-30 1988-08-30 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
CA2036618C (en) * 1990-02-22 2002-10-29 Akira Morimoto Fused thiophene derivatives, their production and use
WO1992003427A1 (en) 1990-08-17 1992-03-05 Yoshitomi Pharmaceutical Industries, Ltd. Ketone compound and remedy for osteoporosis
US5219864A (en) 1991-03-12 1993-06-15 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
DE4227747A1 (de) 1992-08-21 1994-02-24 Basf Ag Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
JPH0776586A (ja) 1993-07-16 1995-03-20 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
WO1996018617A1 (en) 1994-12-12 1996-06-20 Merck & Co., Inc. Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
AU4515696A (en) 1994-12-12 1996-07-03 Merck & Co., Inc. Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
JPH08301849A (ja) 1995-05-01 1996-11-19 Takeda Chem Ind Ltd ヘテロ環化合物およびその製造法
JPH09208496A (ja) 1996-01-30 1997-08-12 Takeda Chem Ind Ltd Lh−rh拮抗物質含有組成物
CA2250908C (en) 1996-04-30 2012-03-13 Takeda Chemical Industries, Ltd. Combined use of gnrh agonist and antagonist
EP0927164A1 (en) * 1996-09-10 1999-07-07 PHARMACIA & UPJOHN COMPANY 8-hydroxy-7-substituted quinolines as anti-viral agents
SK18542000A3 (sk) 1998-06-04 2001-12-03 Abbott Laboratories Protizápalové zlúčeniny inhibujúce bunkovú adhéziu

Also Published As

Publication number Publication date
AU3516200A (en) 2000-09-28
ATE226208T1 (de) 2002-11-15
EP1159279B1 (en) 2002-10-16
NO20014363L (no) 2001-11-08
NZ513758A (en) 2001-09-28
US20020006937A1 (en) 2002-01-17
EA003607B1 (ru) 2003-06-26
ES2184705T3 (es) 2003-04-16
IL145005A0 (en) 2002-06-30
AU759875B2 (en) 2003-05-01
TWI222451B (en) 2004-10-21
PL350651A1 (en) 2003-01-27
EA200100955A1 (ru) 2002-02-28
CN1347417A (zh) 2002-05-01
US6495683B2 (en) 2002-12-17
WO2000053610A2 (en) 2000-09-14
HUP0200324A2 (en) 2002-06-29
DK1159279T3 (da) 2003-02-17
WO2000053610A3 (en) 2001-01-25
DE60000611D1 (en) 2002-11-21
JP2002539130A (ja) 2002-11-19
US6239142B1 (en) 2001-05-29
CA2366609A1 (en) 2000-09-14
BR0008804A (pt) 2002-04-16
CZ20013028A3 (cs) 2002-03-13
HUP0200324A3 (en) 2003-07-28
EP1159279A2 (en) 2001-12-05
NO20014363D0 (no) 2001-09-07
ZA200107255B (en) 2002-12-02
PT1159279E (pt) 2003-02-28
DE60000611T2 (de) 2003-06-26
SK12582001A3 (sk) 2002-02-05
KR20010102543A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
IL145005A0 (en) 4-OXO-4, 7-DIHYDRO-THIENO[2,3-b] PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
AU6607901A (en) Azaindole derivatives, process for their preparation, and their use as antitumoragents
AP2002002455A0 (en) 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dIhydropyrazolo[4,3-D] pyrimidin-7-ones as phosphodiesterase inhibitors.
WO2001019829A3 (en) Pyrazolopyrimidines as therapeutic agents
NO20055510L (no) 2-alkynyl- og 2-alkenylpyrazolo [4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidin-adenosin A2A-reseptorantagonister
ZA200206191B (en) Pyrimidine compounds.
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
CA2279620A1 (en) 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
WO2001094345A3 (en) Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
MXPA02004448A (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
HK1033574A1 (en) Anitumor agents
HK1012341A1 (en) Pyrrolocarbazole
WO2003059878A3 (en) Thieno (3, 2-b) pyridones as antiviral compounds
MXPA04000407A (es) Derivados de fenilacetamido-tiazol, procedimiento para su preparacion y uso como agentes antitumorales.
WO2003059911A3 (en) 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
BR0211214A (pt) 4-tioxo-4,7-dihidro-tieno [2,3-b]piridina-5-carboxamidas como agentes antivirais
CA2412594A1 (en) Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives
TWI255813B (en) Compounds for use as alphavbeta3 receptor antagonists
GEP20063758B (en) Benzothia(Dia)Zine Derivatives and Method for Their Use as AMPA Modulators
MXPA03012039A (es) Derivados de benzo [g]quinolina para tratar glaucoma y miopia.
AU2406700A (en) 3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl(3-(1h-indol-3-yl)-a kyl)-amines
NZ330832A (en) 5-heterocyclyl-alkyl-3-oxo-N-(heteroaryl or aryl)-pyrido[1,2-a]benzimidazole-4-carboxamide derivatives and medicaments